Journal of Infectious Diseases & Preventive Medicine

Journal of Infectious Diseases & Preventive Medicine
Open Access

ISSN: 2329-8731

Martin Braddock

Martin Braddock

Martin Braddock, PhD
AstraZeneca, UK


1981-1984: Ph.D. degree: MRC Radiobiology Unit, Harwell, Didcot, Oxon. with the Christie Hospital, University of Manchester, University of Salford.

University of Dundee, Medical Sciences Institute

1984 – 1987: Post-doctoral Research Assistant, Department of Biochemistry.

University of Oxford, Department of Biochemistry

1991 – 1995: Royal Society Senior Research Fellow. Secured own research funding.

1987 - 1991: Post-doctoral Research Fellow.

Glaxo SmithKline, Gunnel’s Wood Road Stevenage

1999 - 2000: Disease Cell Biology Head, management of up to 65 staff.

1995 - 1999: Research Group Leader, Endothelial Gene Expression Group & Wound Healing and Tissue Regeneration Program, Vascular Diseases Unit, GlaxoWellcome, Stevenage.

2000 - 2004: Associate Director, Discovery Bioscience. Built in vivopharmacology expertise in rheumatoid arthritis and developed AstraZeneca internal and external reputation through scientific symposia.

2004 - 2006: Senior Principal Scientist, Discovery Bioscience, working across the value chain in AstraZeneca. Developed strategic thinking which lead to the CAT alliance and acquisition enabling capability build in biologicals.

2006 - 2009: Director, Discovery Bioscience, management of up to 82 staff with a £6M budget per annum supporting delivery into development of 18 candidate small molecule drugs, 4 candidate biological drugs and project translational science support up to phase IIb clinical development.

2009 – 2011: Chair and Leader, Global Biology Network, Chair and Leader, Global Respiratory and Inflammation Research Area Scientific Leadership Team, Site Science Lead as Senior Principal Scientist, providing leadership to the Global Scientific Ladder.

2010 – present: Global Science Lead for Fostamatinib (R778) phase III project. Responsible for leading pre-clinical, translational and clinical science across all aspects of the value chain reporting to Global VP, Development.

Research Interest

Metabolic diseases, vascular, respiratory and inflammatory/autoimmune disease, HIV and AIDS research, alzheimer's, soft and hard tissue repair and regeneration,small and large molecule drug discovery.